HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhiwei Wang Selected Research

MI 319

5/2010Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.
4/2010MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhiwei Wang Research Topics

Disease

203Neoplasms (Cancer)
04/2022 - 10/2005
50Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2005
40Neoplasm Metastasis (Metastasis)
01/2022 - 03/2006
32Carcinogenesis
01/2022 - 03/2008
28Breast Neoplasms (Breast Cancer)
09/2021 - 05/2006
23Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2006
20Aortic Dissection
01/2022 - 01/2013
17Infections
05/2022 - 03/2011
15Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2010
12Inflammation (Inflammations)
05/2022 - 12/2009
11Stomach Neoplasms (Stomach Cancer)
06/2021 - 03/2011
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2013
9Hypoxia (Hypoxemia)
05/2022 - 01/2012
9Carcinoma (Carcinomatosis)
10/2021 - 09/2007
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 10/2011
7Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 09/2013
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 01/2006
5Abdominal Aortic Aneurysm
04/2022 - 05/2019
5Pain (Aches)
03/2022 - 01/2014
5Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 01/2014
5Liver Neoplasms (Liver Cancer)
01/2022 - 03/2020
5Hypertension (High Blood Pressure)
01/2022 - 03/2020
5Glioma (Gliomas)
01/2022 - 01/2014
5Leukemia
12/2021 - 01/2002
5Reperfusion Injury
01/2020 - 12/2016
4Hyperplasia
05/2022 - 01/2021
4Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 12/2019
4Neointima
05/2022 - 01/2020
4Adenocarcinoma
10/2021 - 12/2010
4Thrombosis (Thrombus)
07/2021 - 01/2016
4Renal Cell Carcinoma (Grawitz Tumor)
02/2021 - 09/2019
4Hyperglycemia
01/2021 - 05/2014
4Edema (Dropsy)
01/2021 - 12/2014
4Fibrosis (Cirrhosis)
12/2020 - 10/2014
4Lung Neoplasms (Lung Cancer)
06/2020 - 08/2015
4Acute Lung Injury
03/2020 - 01/2016
4Virus Diseases (Viral Diseases)
01/2017 - 05/2015
4Scoliosis
05/2016 - 07/2011

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2006
36MicroRNAs (MicroRNA)IBA
01/2021 - 08/2009
32Biological ProductsIBA
02/2022 - 03/2008
29NF-kappa B (NF-kB)IBA
01/2011 - 10/2005
26Pharmaceutical PreparationsIBA
04/2022 - 04/2007
18GemcitabineFDA Link
10/2021 - 10/2005
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 03/2006
173,3'-diindolylmethane (diindolylmethane)IBA
10/2011 - 05/2006
16CurcuminIBA
12/2019 - 06/2006
14Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2010
14GenisteinIBA
01/2016 - 10/2005
13DNA (Deoxyribonucleic Acid)IBA
08/2019 - 03/2006
12Transcription Factors (Transcription Factor)IBA
06/2022 - 11/2006
12IsoflavonesIBA
11/2020 - 10/2005
12Small Interfering RNA (siRNA)IBA
01/2019 - 03/2006
11Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 11/2011
10Messenger RNA (mRNA)IBA
01/2022 - 11/2010
9Insulin (Novolin)FDA Link
01/2021 - 01/2006
9Androgen Receptors (Androgen Receptor)IBA
01/2020 - 10/2006
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 07/2009
7Circular RNAIBA
01/2022 - 10/2020
7Long Noncoding RNAIBA
09/2021 - 12/2017
7Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 10/2005
7Angiotensin IIIBA
03/2020 - 01/2013
7Cisplatin (Platino)FDA LinkGeneric
01/2020 - 02/2007
7Phosphotransferases (Kinase)IBA
01/2019 - 01/2006
7Matrix Metalloproteinases (MMPs)IBA
12/2017 - 03/2006
7Arsenic Trioxide (Trisenox)FDA Link
01/2017 - 01/2002
7S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
10/2016 - 01/2012
7Platelet-Derived Growth FactorIBA
01/2016 - 12/2007
6Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 03/2010
6EnzymesIBA
01/2021 - 04/2010
6rottlerinIBA
01/2018 - 01/2016
6F-Box ProteinsIBA
04/2016 - 01/2012
5Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 08/2011
5Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2015
5Therapeutic UsesIBA
01/2021 - 10/2008
5Cadherins (E-Cadherin)IBA
02/2020 - 11/2012
5Blood Glucose (Blood Sugar)IBA
01/2019 - 09/2007
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2018 - 05/2012
5SurvivinIBA
06/2010 - 05/2006
5indole-3-carbinolIBA
06/2010 - 11/2006
4HydrogelsIBA
05/2022 - 12/2020
4Peptides (Polypeptides)IBA
01/2022 - 06/2006
4CateninsIBA
01/2021 - 07/2014
4Estrogen ReceptorsIBA
04/2020 - 02/2008
4RNA (Ribonucleic Acid)IBA
12/2019 - 05/2015
4Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2017 - 12/2013
4Epithelial Cell Adhesion MoleculeIBA
02/2014 - 08/2011
4thiazolyl blueIBA
10/2011 - 03/2006
4Docetaxel (Taxotere)FDA Link
10/2011 - 04/2007
4Complementary DNA (cDNA)IBA
07/2010 - 03/2006
4LigandsIBA
03/2010 - 01/2006

Therapy/Procedure

78Therapeutics
05/2022 - 01/2006
18Drug Therapy (Chemotherapy)
01/2021 - 09/2007
13Transplantation
01/2021 - 01/2006
11Cell Transplantation
01/2015 - 09/2007
5Immunotherapy
10/2021 - 01/2019
5Length of Stay
01/2021 - 11/2014
5Chemoprevention
01/2016 - 02/2008
4Endovascular Aneurysm Repair
04/2022 - 01/2020
4Surgical Amputation (Amputations)
04/2022 - 01/2020